Antitumor effect of photodynamic therapy with photosensitizer Photoran E6 on melanoma B-16 and response of mouse peripheral blood to PDT

«Radiation and Risk», 2022, vol. 31, No. 3, pp.77-86

DOI: 10.21870/0131-3878-2022-31-3-77-86


Abramova O.B. – Head of Lab., C. Sc., Biol. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: + 7 910 510 08 62; е-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Drozhzhina V.V. – Researcher
Kozlovtseva E.A. – Researcher
Sivovolova T.P. – Researcher. A. Tsyb MRRC.
Kaprin A.D. – General Director, Academician of RAS, MD, Prof. NMRRC.
A. Tsyb MRRC, Obninsk
1NMRRC, Moscow


Photodynamic therapy (PDT) is the effective method for the total eradication of some types of solid malignant neoplasms. The paper presents results of research on the effectiveness of PDT of the melanoma B-16 with the intraperitoneally injected novel Russian photosensitizer (PS) "Photoran E6". To assess the response of melanoma to PDT, the following indicators were used: tumor growth inhi-bition index (TGI,%), tumor regression rate (%), absolute tumor growth rate (K) in mice with continued neoplasia growth. To assess the proportion of peripheral blood cells and their morphological characteristics the therapy efficiency integrated health indicators were used: increase in life expectancy (ILE,%) of mice under study in comparison with the control and the proportion of cured animals on the 90th day after PDT. The results of the study demonstrate high antitumor efficacy of Photoran E6 for PDT of mouse melanoma. The observed changes in hemogram parameters and in leukocyte indices also indicate the effectiveness of the therapy, changes in the control samples indicate the spread of the malignant process, proliferative processes, impaired normal regeneration of blood elements, severe intoxication that cause destruction and degeneration of blood cells and drastic changes in the course of immune response.

Key words
melanoma, photodynamic therapy, tumor regression, leukogram, integrated medical indicators, Photoran E6.


1. Abramova O.B., Yuzhakov V.V., Kaplan M.A., Drozhzhina V.V., Beregovskaya E.A., Churikova T.P., Sevan’kaeva L.E., Fomina N.K., Tsyganova M.G., Ivanov S.A., Kaprin A.D. Photodynamic therapy of sarcoma M-1 in rats with photosensitizer Photoran E6. Bull. Exp. Biol. Med., 2021, vol. 170, no. 4, pp. 479-484. DOI: 10.1007/s10517-021-05092-9.

2. Abramova O.B., Kaplan M.A., Yuzhakov V.V., Drozhzhina V.V., Bandurko L.N., Yakovleva N.D., Churikova T.P., Kozlovtseva E.A., Ivanov S.A., Kaprin A.D. Anti-tumor efficacy of photodynamic therapy of Ehrlich mice carcinoma with the new photosensitizer Photoran E6. Radiatsia i risk – Radiation and Risk, 2022, vol. 31, no. 2, pp. 162-173. DOI: 10.21870/0131-3878-2022-31-2-162-173. (In Russian).

3. Abramova O.B., Demyashkin G.A., Drozhzhina V.V., Yakovleva N.D., Kozlovtseva E.A., Sivovolova T.P., Shegay P.V., Ivanov S.A., Kaprin A.D. On the pathomorphological pattern of the efficiency of photodynamic therapy of murine melanoma B16 using a new photosensitizer based on chlorin e6 conjugate with a prostate-specific membrane antigen. Molecules, 2022, vol. 27, no. 11, pp. 34-45. DOI: 10.3390/molecules27113445.

4. Abramova O.B., Drozhzhina V.V., Churikova T.P., Kozlovtseva E.A., Arkhipova L.M., Kaplan M.A., Ivanov S.A., Kaprin A.D. Photodynamic therapy of the experimental tumors of different morphological types with liposomal boronated chlorin е6. Biomedical Photonics, 2021, vol. 10, no. 3, pp. 12-22. DOI: 10.24931/2413-9432-2021-10-3-12-22. (In Russian).

5. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., Korbelik M., Moan J., Mroz P., Nowis D., Piette J., Wilson B.C., Golab J. Photodynamic therapy of cancer: an update. CA Cancer J. Clin., 2011, vol. 61, no. 4, pp. 250-281. DOI: 10.3322/caac.20114.

6. Filonenko E.V. Clinical implementation and scientific development of photodynamic therapy in Russia in 2010-2020. Biomedical Photonics, 2021, vol. 10, no. 4, pp. 4-22. DOI: 10.24931/2413-9432-2021-9-4-4-22. (In Russian).

7. Allison R.R., Moghissi K. Photodynamic therapy (PDT): PDT mechanisms. Clin. Endosc., 2013, vol. 46, no. 1, pp. 24-29. DOI: 10.5946/ce.2013.46.1.24.

8. Milstein D.M., van Kuijen A.M., Copper M.P., Karakullukçu B., Tan I.B., Lindeboom J.A., Fokkens W.J. Monitoring microcirculatory alterations in oral squamous cell carcinoma following photodynamic therapy. Photodiagnosis Photodyn. Ther., 2012, vol. 9, no. 1, pp. 69-75. DOI: 10.1016/j.pdpdt.2011.11.001.

9. Senge M.O., Radomski M.W. Platelets, photosensitizers, and PDT. Photodiagnosis Photodyn. Ther., 2013, vol. 10, no. 1, pp. 1-16. DOI: 10.1016/j.pdpdt.2012.08.004.

10. Mezhirova N.M., Danilova V.V., Ovcharenko S.S. Pathophysiological and diagnostic aspects of the syn-drome of systemic inflammatory response. Medittsina neotlozhnyh sostoyanij – Medicine of Urgent Conditions, 2011, vol. 1-2, pp. 32-33. (In Russian).

11. Abakushina E.V., Romanko Yu.S., Kaplan M.A., Kaprin A.D. Anticancer immune response and photody-namic therapy. Radiatsia i risk – Radiation and Risk, 2014, vol. 23, no. 4, pp. 92-98. (In Russian).

12. Gafton G.I., Anisimov V.V., Gelfond M.L., Semiletova Yu.V., Baldueva I.A., Nekhaeva Т.L., Novik A.V., Myasnyankin М.Yu. Clinical-immunological assessment of efficacy of neoadjuvant photodynamic therapy in surgical management of primary melanoma. Sibirskij onkologicheskij zhurnal – Siberian Journal of Oncology, 2015, vol. 1, no. 2, pp. 31-38. (In Russian).

13. Allergology and clinical immunology. Eds.: R.M Hayitov., N.I. Ilyina. Moscow, GEOTAR-Media, 2019. 352 p. (In Russian).

14. Sokolov A.V., Shmidt A.A., Lomakin Y.A. B cell regulation in autoimmune diseases. Acta Naturae, 2018, vol. 10, no. 3, pp. 11-22. DOI: 10.32607/20758251-2018-10-3-11-22.

15. Purtshwanidze V.A., Simakov Y.G. Influence of photoditazine during photodynamic therapy of malignant tumors on the aggregation of erythrocytes of peripheral blood. Rossijskij bioterapevticheskij zhurnal – Russian Biotherapeutic Journal, 2016, vol. 15, no. 1, pp. 93-94. (In Russian).

16. Filipuk A.L., Zenin V.V. Prognostic value of integral medical indicators during chronic heart failure. Modern medicine: topical issues: collection of articles LIV-LV international. Scientific and practical conference. Novo-sibirsk, SibAK, 2016, no. 4-5, pp. 24-30. (In Russian).

17. Ostrovsky V.K., Kishenina L.A., Plaxina N.S. Some blood and leukocyte index of intoxication in malignant tumors. Voprosy onkologii – Oncology Questions, 2005, no. 5, pp. 567-570. (In Russian).

Full-text article (in Russian)